Product Brochure: NASH drug discovery using human organ-on-chips
3 August 2020

In this application note, CN BIO discusses how the PhysioMimix™ OOC enables advanced long term in vitro liver cultures and modelling of different stages of NAFLD/ NASH disease in a range of culture conditions. This physiologically relevant assay is designed to help fast-track the investigation of new therapies for this chronic liver disease.